HACE1 is a tumor suppressor gene candidate in natural killer cell neoplasms

American Journal of Pathology

Volumn 182, Issue 1, 2013, Pages 49-55

  Küçük, Can ^a   Hu, Xiaozhou ^a,c   Iqbal, Javeed ^a   Gaulard, Philippe ^d   Klinkebiel, David ^a   Cornish, Adam ^b   Dave, Bhavana J ^b   Chan, Wing C ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c PEKING UNIVERSITY THIRD HOSPITAL   (China)

^d HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HACE1 PROTEIN; INTERLEUKIN 2; MESSENGER RNA; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ALLELE; APOPTOSIS; ARTICLE; BIOPSY; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; GENE SILENCING; HOMEOSTASIS; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; METHYLATION; NATURAL KILLER CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR UPREGULATION; RNA TRANSCRIPTION;

APOPTOSIS; CELL CYCLE CHECKPOINTS; COCULTURE TECHNIQUES; CPG ISLANDS; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; INTERLEUKIN-2; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOMA, NON-HODGKIN; TUMOR CELLS, CULTURED; UBIQUITIN-PROTEIN LIGASES; UP-REGULATION;

EID: 84871333633     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.09.012     Document Type: Article

References (29)

1. F. Bernassola, M. Karin, A. Ciechanover, and G. Melino The HECT family of E3 ubiquitin ligases: multiple players in cancer development Cancer Cell 14 2008 10 21 (Pubitemid 351885498)
2. L. Zhang, M.S. Anglesio, M. O'Sullivan, F. Zhang, G. Yang, R. Sarao, P.N. Mai, S. Cronin, H. Hara, N. Melnyk, L. Li, T. Wada, P.P. Liu, J. Farrar, R.J. Arceci, P.H. Sorensen, and J.M. Penninger The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers Nat Med 13 2007 1060 1069 (Pubitemid 47517503)
3. M.S. Anglesio, V. Evdokimova, N. Melnyk, L. Zhang, C.V. Fernandez, P.E. Grundy, S. Leach, M.A. Marra, A.R. Brooks-Wilson, J. Penninger, and P.H. Sorensen Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney Hum Mol Genet 13 2004 2061 2074 (Pubitemid 39377829)
4. K. Hibi, M. Sakata, K. Sakuraba, A. Shirahata, T. Goto, H. Mizukami, M. Saito, K. Ishibashi, G. Kigawa, H. Nemoto, and Y. Sanada Aberrant methylation of the HACE1 gene is frequently detected in advanced colorectal cancer Anticancer Res 28 2008 1581 1584 (Pubitemid 351892933)
5. M. Sakata, Y.H. Kitamura, K. Sakuraba, T. Goto, H. Mizukami, M. Saito, K. Ishibashi, G. Kigawa, H. Nemoto, Y. Sanada, and K. Hibi Methylation of HACE1 in gastric carcinoma Anticancer Res 29 2009 2231 2233
6. Y. Huang, A. de Reynies, L. de Leval, B. Ghazi, N. Martin-Garcia, M. Travert, J. Bosq, J. Briere, B. Petit, E. Thomas, P. Coppo, T. Marafioti, J.F. Emile, M.H. Delfau-Larue, C. Schmitt, and P. Gaulard Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type Blood 115 2010 1226 1237
7. K. Karube, M. Nakagawa, S. Tsuzuki, I. Takeuchi, K. Honma, Y. Nakashima, N. Shimizu, Y.H. Ko, Y. Morishima, K. Ohshima, S. Nakamura, and M. Seto Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK cell neoplasms by genomic and functional analyses Blood 118 2011 3195 3204
8. J. Zhao, Z. Zhang, Z. Vucetic, K.J. Soprano, and D.R. Soprano HACE1: a novel repressor of RAR transcriptional activity J Cell Biochem 107 2009 482 493
9. S. Torrino, O. Visvikis, A. Doye, L. Boyer, C. Stefani, P. Munro, J. Bertoglio, G. Gacon, A. Mettouchi, and E. Lemichez The E3 ubiquitin-ligase HACE1 catalyzes the ubiquitylation of active Rac1 Dev Cell 21 2011 959 965
10. K.A. Moore, R. Sethi, A.M. Doanes, T.M. Johnson, J.B. Pracyk, M. Kirby, K. Irani, P.J. Goldschmidt-Clermont, and T. Finkel Rac1 is required for cell proliferation and G2/M progression Biochem J 326 Pt 1 1997 17 20 (Pubitemid 27386912)
11. D. Tang, Y. Xiang, S. De Renzis, J. Rink, G. Zheng, M. Zerial, and Y. Wang The ubiquitin ligase HACE1 regulates Golgi membrane dynamics during the cell cycle Nat Commun 2 2011 501
12. C. Kucuk, J. Iqbal, X. Hu, P. Gaulard, L. De Leval, G. Srivastava, W.Y. Au, T.W. McKeithan, and W.C. Chan PRDM1 is a tumor suppressor gene in natural killer cell malignancies Proc Natl Acad Sci U S A 108 2011 20119 20124
13. W. Tam, M. Gomez, A. Chadburn, J.W. Lee, W.C. Chan, and D.M. Knowles Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas Blood 107 2006 4090 4100 (Pubitemid 43726818)
14. C.B. Lozzio, and B.B. Lozzio Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome Blood 45 1975 321 334
15. S.S. Somanchi, V.V. Senyukov, C.J. Denman, and D.A. Lee Expansion, purification, and functional assessment of human peripheral blood NK cells J Vis Exp 48 2011 pii: 2540
16. J. Iqbal, C. Kucuk, R.J. Deleeuw, G. Srivastava, W. Tam, H. Geng, D. Klinkebiel, J.K. Christman, K. Patel, K. Cao, L. Shen, K. Dybkaer, I.F. Tsui, H. Ali, N. Shimizu, W.Y. Au, W.L. Lam, and W.C. Chan Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies Leukemia 23 2009 1139 1151
17. M.P. Ball, J.B. Li, Y. Gao, J.H. Lee, E.M. LeProust, I.H. Park, B. Xie, G.Q. Daley, and G.M. Church Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells Nature Biotechnol 27 2009 361 368
18. D. van de Wetering, R.A. de Paus, J.T. van Dissel, and E. van de Vosse IL-23 modulates CD56+/CD3- NK cell and CD56+/CD3+ NK-like T cell function differentially from IL-12 Int Immunol 21 2009 145 153
19. Y. Huang, A. de Reynies, L. de Leval, B. Ghazi, N. Martin-Garcia, M. Travert, J. Bosq, J. Briere, B. Petit, E. Thomas, P. Coppo, T. Marafioti, J.F. Emile, M.H. Delfau-Larue, C. Schmitt, and P. Gaulard Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type Blood 115 2010 1226 1237
20. E.R. Hyytinen, R. Saadut, C. Chen, L. Paull, P.A. Koivisto, R.L. Vessella, H.F. Frierson Jr., and J.T. Dong Defining the region(s) of deletion at 6q16-q22 in human prostate cancer Genes Chromosomes Cancer 34 2002 306 312 (Pubitemid 34553309)
21. M. Inoue, A. Marx, A. Zettl, P. Strobel, H.K. Muller-Hermelink, and P. Starostik Chromosome 6 suffers frequent and multiple aberrations in thymoma Am J Pathol 161 2002 1507 1513
22. Y. Zhang, P. Matthiesen, S. Harder, R. Siebert, G. Castoldi, M.J. Calasanz, K.F. Wong, A. Rosenwald, G. Ott, N.B. Atkin, and B. Schlegelberger A 3-cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization Genes Chromosomes Cancer 27 2000 52 58
23. Z. Yue, S. Jin, C. Yang, A.J. Levine, and N. Heintz Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor Proc Natl Acad Sci U S A 100 2003 15077 15082 (Pubitemid 37518019)
24. J.G. Herman, and S.B. Baylin Gene silencing in cancer in association with promoter hypermethylation N Engl J Med 349 2003 2042 2054 (Pubitemid 37448928)
25. P.A. Jones, and S.B. Baylin The fundamental role of epigenetic events in cancer Nat Rev Genet 3 2002 415 428 (Pubitemid 34587077)
26. T. Oka, M. Ouchida, M. Koyama, Y. Ogama, S. Takada, Y. Nakatani, T. Tanaka, T. Yoshino, K. Hayashi, N. Ohara, E. Kondo, K. Takahashi, J. Tsuchiyama, M. Tanimoto, K. Shimizu, and T. Akagi Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas Cancer Res 62 2002 6390 6394 (Pubitemid 35364092)
27. L.L. Siu, J.K. Chan, K.F. Wong, and Y.L. Kwong Specific patterns of gene methylation in natural killer cell lymphomas: p73 is consistently involved Am J Pathol 160 2002 59 66 (Pubitemid 34052266)
28. C. Kucuk, J. Iqbal, X. Hu, P. Gaulard, L. De Leval, G. Srivastava, W.Y. Au, T.W. McKeithan, and W.C. Chan PRDM1 is a tumor suppressor gene in natural killer cell malignancies Proc Natl Acad Sci U S A 108 2011 20119 20124
29. A.L. Shaffer, K.I. Lin, T.C. Kuo, X. Yu, E.M. Hurt, A. Rosenwald, J.M. Giltnane, L. Yang, H. Zhao, K. Calame, and L.M. Staudt Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program Immunity 17 2002 51 62 (Pubitemid 34874618)